Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes

A Koitka, Z. Cao, P. Koh, A. M D Watson, K. C. Sourris, Laurent Loufrani, A Soro-Paavonen, T Walther, K. J. Woollard, K. A M Jandeleit-Dahm, M. E. Cooper, T. J. Allen

Research output: Contribution to journalArticleResearchpeer-review

29 Citations (Scopus)

Abstract

Aims/hypothesis: Most of the known actions of angiotensin II have been considered primarily to be the result of angiotensin II subtype 1 receptor activation. However, recent data suggest that the angiotensin II subtype 2 receptor (AT2R) may modulate key processes linked to atherosclerosis. The aim of this study was to investigate the role of AT2R in diabetes-associated atherosclerosis using pharmacological blockade and genetic deficiency. Methods: Aortic plaque deposition was assessed in streptozotocin-induced diabetic apolipoprotein E (Apoe) knockout (KO) and At 2 r (also known as Agtr2)/Apoe double-KO (DKO) mice. Control and diabetic Apoe-KO mice received an AT2R antagonist PD123319 (5 mg kg-1 day-1) via osmotic minipump for 20 weeks (n = 7-8 per group). Results: Diabetes was associated with a sixfold increase in plaque area (diabetic Apoe-KO: 12.7 ± 1.4% vs control Apoe-KO: 2.3 ± 0.4%, p < 0.001) as well as a significant increase in aortic expression of the gene At 2 r (also known as Agtr2). The increase in plaque area with diabetes was attenuated in AT2R antagonist-treated diabetic Apoe-KO mice (7.1 ± 0.5%, p < 0.05) and in diabetic At 2 r/Apoe DKO mice (9.2 ± 1.3%, p < 0.05). These benefits occurred independently of glycaemic control or BP, and were associated with downregulation of a range of pro-inflammatory cytokines, adhesion molecules, chemokines and various extracellular matrix proteins. Conclusions/interpretation: This study provides evidence for AT2R playing a role in the development of diabetes-associated atherosclerosis. These findings suggest a potential utility of AT2R blockers in the prevention and treatment of diabetic macrovascular complications.

Original languageEnglish
Pages (from-to)584-592
Number of pages9
JournalDiabetologia
Volume53
Issue number3
DOIs
Publication statusPublished - Mar 2010
Externally publishedYes

Keywords

  • Apoe-KO mouse
  • ATR
  • Atherosclerosis
  • Diabetes

Cite this